arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2610.39714cs.AI
收藏

MoLRSI:用于分子发现的递归自我改进智能体

MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

Northeastern University(东北大学);Broad Institute of MIT and Harvard(麻省理工学院与哈佛大学博德研究所);Harvard University(哈佛大学);Wyss Institute for Biologically Inspired Engineering, Harvard University(哈佛大学怀斯生物启发工程研究所);Massachusetts Institute of Technology(麻省理工学院);University of California, Berkeley(加州大学伯克利分校);University of Toronto(多伦多大学);The Ohio State University(俄亥俄州立大学);University of Washington(华盛顿大学);Howard Hughes Medical Institute(霍华德·休斯医学研究所);Yale University(耶鲁大学);Microsoft Research New England(微软研究院新英格兰分部);Massachusetts General Hospital(麻省总医院);Brigham and Women’s Hospital and Dana-Farber Cancer Institute(布莱根妇女医院与丹娜法伯癌症研究院)
Yikun Zhang, Xiwei Cheng, Mingze Yuan, Yu Zhang, Brian Shim, Aarti Krishnan, Daniel Rosen, Kunyang Sun, Yingze Wang, Zhenfeng Deng, Botao Yu, Bingxu Liu, David … 展开作者

Yikun Zhang, Xiwei Cheng, Mingze Yuan, Yu Zhang, Brian Shim, Aarti Krishnan, Daniel Rosen, Kunyang Sun, Yingze Wang, Zhenfeng Deng, Botao Yu, Bingxu Liu, David Liu, Tianyu Liu, Yuanqi Du, Nir Hacohen, James J. Collins, Wengong Jin

AI总结:

本研究提出MoLRSI智能体,结合工作流与模型架构优化及跨任务记忆,在抗生素发现和肽-MHC结合剂设计中,其工作流的实验命中率优于专家主导流程,且Claude Science未成功。

摘要:

分子发现需要在广阔的组合搜索空间中进行探索,同时平衡相互竞争的生物学目标。AI智能体可自动化专家定义的分子设计流程,但仅自动化无法解决如何针对新任务优化工作流,或通过经验改进其开发的问题。本文提出MoLRSI,一种结合工作流与模型架构系统优化、具备持久跨任务记忆的AI智能体,可递归改进分子发现的搜索策略。工作流性能、优化结果与执行反馈指导后续搜索,使智能体同时改进工作流及开发策略。我们在两项需平衡竞争属性的挑战性分子发现场景中评估MoLRSI:抗生素发现中,MoLRSI开发了平衡抗菌活性、细胞毒性与结构新颖性的筛选工作流,实验命中率达15.9%,而采用相同训练数据与筛选库的先前专家主导工作流命中率为8.7%;从头肽-MHC结合剂设计中,MoLRSI开发的工作流同时考虑目标结合性与特异性,针对MART-1和SARS-CoV-1 pMHC产生8个实验验证的命中分子,对测试脱靶的结合具有偏好性,而Claude Science完全未成功。这些发现表明,经验引导的工作流优化可解决竞争发现目标,同时改进后续研究使用的搜索策略。

英文摘要:

Molecular discovery requires navigating vast combinatorial search spaces while balancing competing biological objectives. AI agents can automate expert-defined molecular design protocols, but automation alone does not address how to optimize workflows for new tasks or improve their development through experience. Here we introduce MoLRSI, an AI agent that combines systematic optimization of workflows and model architectures with persistent cross-task memory to recursively improve its search policy for molecular discovery. Workflow performance, refinement outcomes, and execution feedback guide subsequent searches, allowing the agent to improve both its workflows and its strategy for developing them. We evaluate MoLRSI in two challenging molecular discovery settings that require balancing competing properties. In antibiotic discovery, MoLRSI developed a screening workflow balancing antibacterial activity, cytotoxicity and structural novelty, achieving an experimental hit rate of 15.9%, compared with 8.7% for a previous expert-led workflow using the same training data and screening library. In de novo peptide-MHC binder design, MoLRSI developed workflows that jointly consider target binding and specificity, producing eight experimentally validated hits against MART-1 and SARS-CoV-1 pMHCs with preferential binding over tested off-targets while Claude Science completely failed. These findings demonstrate how experience-guided workflow optimization can address competing discovery objectives while improving the search strategies used in subsequent campaigns.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑